Schedule 13G ownership disclosure
ALAUNOS THERAPEUTICS INC
Common Stock, $0.001 par value per share · CUSIP: 98973P309
Event date: 2025-08-21
- Filing-level shares
- 149,827.00
- Percent of class
- 6.8%
- Strategic EP, LLC
Shares: 149,827.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-084258
- Form type
- SCHEDULE 13G
- Filer
- Alaunos Therapeutics, Inc.
- CIK
- CIK 1107421
- Filed
- Sep 04, 2025
- Reporting period
- Aug 21, 2025
- Description
- Schedule 13G beneficial ownership